Boris Sepesi MD FACS

Thoracic Surgery, Lung Cancer, Esophageal Cancer, Mesothelioma

[Vala Afshar @ValaAfshar]

Life lessons from @rogerfederer (must watch)

1 Effortless is a myth
2 Belief in yourself has to be earned
3 Grit > Gift
4 Discipline is talent
5 Trust and loving the process is talent
6 You can do your best and still lose
7 Life is bigger than the court

[Boris Sepesi MD FACS @BorisSepesi]

@ShandaBlackmon It is about exposure and how much fun it is to dissect those nodes versus how much of a chore it is. Robotics allows visualization exposure and fine dissection. Also the pace of dissection and comfort is different. I believe these are purely the factors. VATS requires more grit.

[Boris Sepesi MD FACS @BorisSepesi]

@jdoningtonmd Enjoy

[Boris Sepesi MD FACS @BorisSepesi]

@rjmehran @maraantonoff Congratulations Madame Vice President.

[Mara Antonoff, MD, FACS @maraantonoff]

I’m so proud of our @MDAndersonNews CT Surgery Jeopardy finalists, Drs @KGMitchellMD and @DavidNelsonMD! Come cheer for them in the exhibit hall this morning! @TSRA_official @ThoracicStudent #STS2023

[Mara Antonoff, MD, FACS @maraantonoff]

I am one proud program director today! Our @MDAndersonNews thoracic surgery fellows, Drs @KGMitchellMD and @DavidNelsonMD won the CTSurgery showdown championship today! I’m so happy that the final jeopardy was “who was lariche?” #STS2023 @STS_CTsurgery https://t.co/y71rhH7Dl3

[Eric K. Singhi, MD @lungoncdoc]

🎉 12 days till 2023

‼️ Quick 2022 snapshot review of @FDAOncology treatment approvals for our patients with lung cancer 👇🏽 #lcsm #lungcancer @OncoAlert

[Vivek Subbiah, MD @VivekSubbiah]

⭐️Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors @NaturePortfolio
https://t.co/wLdNr7bfzy

[Boris Sepesi MD FACS @BorisSepesi]

@AlexisChidi @hopkinssurgery @MDAndersonNews @SocietyofBAS Congratulations

[Brendon Stiles @BrendonStilesMD]

Indeed. Complete response from crowd who loved and benefited from the tag team talk!

[Jonathan Spicer MD PhD @DoctorJSpicer]

To all thoracic surgeons: Have faith in your #medonc colleagues and witness the impact of neoadj chemoIO on QOL! @STS_CTsurgery @AATSHQ @thoracic @ThoracicsCanada @EnriquetaFelip @SBroderickMD @BorisSepesi @maraantonoff @ekslim @BrendonStilesMD @ElliotServaisMD @ASCOPost @myESMO

[Sam Sater, MD @HSaterMD]

Dr Tina Cascone @MDAndersonNews presented an amazing review of NIO in lung cancer #LCSM and highlighted NeoCoast Study. She also called for reverse translation @sitcancer #SITC22

[AATS Journals @AATSJournals]

Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with #NSCLC. Read the full #JTCVS article by @BorisSepesi, Cascone, et al: https://t.co/yve3XgcqlS @tssmn @nicolaszhoudo @rjmehran @maraantonoff @mvnegrao @AnneTsao2 @AraVaporciyan @sgswisher

[M.Provencio @MARIANOPROVENCI]

NADIM II suggests PFS, OS benefits of nivolumab + chemo in resectable NSCLC - https://t.co/v4Ts4aaKl9 #GoogleAlerts

[Balazs Halmos @BalazsHalmosMD]

@StephenVLiu @benlevylungdoc Just adding some more arguments to appeal to an international audience😉

[Shanda Blackmon, MD, MPH @ShandaBlackmon]

Looking forward to telling the story of why I wear pearls in the OR at GRIT tomorrow #GRIT2022 @MayoClinic @MayoClinicSurg

[Reza Mehran, MD @rjmehran]

MD Anderson was honored with the presence of Dr. David Harpole from Duke University for the @MDAndersonNews 2022 Jack A. Roth Distinguished Lecturer in the Thoracic Surgery Research. In the process he also became an honorary Texan!

[Boris Sepesi MD FACS @BorisSepesi]

@mtmdphd @JackWestMD @ADesaiMD @AnaVManana @JAMAOnc So the question really is whether it is easier to recover from neoadjuvant therapy to proceed with surgery or recover from surgery to proceed with adjuvant therapy. Historically ~90% proceeded to surgery after chemo but only ~60% received adjuvant chemo. New era now.

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

Perioperative Therapy in Early-Stage Lung Cancer [July 28, 2022] @ADesaiMD @AnaVManana @JackWestMD @JAMAOnc Patient Page https://t.co/IMhc303GgY #lcsm

[Boris Sepesi MD FACS @BorisSepesi]

@BrendonStilesMD @DoctorJSpicer @cusm_muhc North Star and Bright Star results with shed some light on this in stage IV. It is not a comparison between surgery and RT. Both are valid LCT modalities. Benefit of surgery following TKI is getting final path report of response. All therapies complement each other over time.